By Lucy Parkinson, VP of Investor Research, LSN
On November 5th, RESI is coming back to New York, and will bring an agenda full of investor discussions and content on key investor constituencies and life science technology verticals.
RESI NYC includes new panels on AI in Healthcare and Funding NYC’s Earliest Stage Companies, plus the return of the expert sessions on Investing in Oncology Innovation and Asia Cross-Border Investors. RESI will also present panels on our core technology verticals of Early Stage Therapeutics, Medical Devices, Diagnostics, and Digital Health, and on key investor types such as Angels and Family Offices, Seed Funds, Corporate Venture Capital and Big Pharma. You can view the entire agenda below. If you’d like to here from experienced investors on these key topics and book face-to-face meetings with investors all day, you can register now.
Leave a Reply